Bio-Techne
TECH
#1708
Rank
S$13.15 B
Marketcap
$83.23
Share price
0.85%
Change (1 day)
-16.87%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2023 (TTM): $2.11

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $2.12. In 2022 the company made an earnings per share (EPS) of $2.25 an increase over its 2021 EPS that were of $1.81.

EPS history for Bio-Techne from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.11-6.2%
2022$2.2524.35%
2021$1.8117.98%
2020$1.54-10.94%
2019$1.73101.57%
2018$0.86-17.53%
2017$1.0439.37%
2016$0.74-17.23%
2015$0.90-14.97%
2014$1.061.29%
2013$1.043.68%
2012$1.01-1.97%
2011$1.031.67%
2010$1.017.14%
2009$0.94-1.06%
2008$0.9519.41%
2007$0.8019.1%
2006$0.6710.56%
2005$0.6129.5%
2004$0.4713.05%
2003$0.4168.43%
2002$0.25-17.05%
2001$0.3017.33%
2000$0.2548.51%
1999$0.1723.17%
1998$0.1413.89%
1997$0.1242.57%
1996$0.08509

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$20.68 877.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.71-464.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.48 253.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.81 410.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.96-7.38%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$11.52 444.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.27-159.87%๐Ÿ‡บ๐Ÿ‡ธ USA